logo

Sector: Pharmaceuticals & Biotechnology

|

Large Cap

Sun Pharmaceutical Share Price

Sun Pharmaceutical Industries Ltd.

1,862.30

-12.10(-0.65%)
25th Jun 2026 | 3:28 PM
NSE : SUNPHARMA
Open Free Demat Account

By signing up I certify terms, conditions & privacy policy

Sun Pharmaceutical Performance

Price Movement

₹1862.30

₹1858.00

₹1887.00

Today's LowToday's High

1 Year Performance

₹1862.30

₹1548.00

₹1916.60

52 Week Low52 Week High

Markets Today

High₹1,887.00
Low₹1,858.00
Open at₹1,870.00
Prev Close₹1,874.40
Volumes18.16 L
Avg Price₹1,869.29
Lower Circuit₹1,687.00
Upper Circuit₹2,061.80

Historical Performance

3M High₹1,916.60
3M Low₹1,613.60
1 Yr High₹1,916.60
1 Yr Low₹1,548.00
3 Yr High₹1,960.35
3 Yr Low₹986.00
5 Yr High₹1,960.35
5 Yr Low₹664.20

Summary

As of 26-06-2026 04:20, Sun Pharmaceutical Industries Ltd. share price today is ₹0, with a change of ₹-1874.40 (-100.00%) from the previous close of ₹1874.4. The stock opened at ₹1870 and traded between ₹1858 and ₹1887, with a total traded volume of 1816438 shares. The company has a market capitalization of ₹446948.1 Cr in the Pharmaceuticals & Biotechnology sector. while its 52-week high and low are ₹1916.6 and ₹1548, respectively.

Sun Pharmaceutical Industries Ltd. valuation metrics include a P/E ratio of 38.9, EPS of ₹47.8, and book value of ₹5.30. Profitability indicators show ROE of 13.73% along with a dividend yield of 0.9%. Sun Pharmaceutical Industries Ltd. has reported revenue of ₹58462.04 Cr and net profit of ₹11479.42 Cr.

Sun Pharmaceutical Industries Ltd. technical indicators include Day RSI at 66.93, Day MFI at 78.06, Day ADX at 17.39. Additional indicators include Commodity Channel Index (CCI) at 166.7 and Williams %R at -20.54. Momentum indicators show Day MACD at 13.13, Day MACD Signal Line at 5.45, DayATR at 30.5. Rate of Change indicators for Sun Pharmaceutical Industries Ltd. include ROC125 at 7.36 and ROC21 at 1.84.

Exponential moving averages include EMA5 at ₹1855.5, EMA10 at ₹1838.5, EMA12 at ₹1834.6, EMA20 at ₹1826, EMA26 at ₹1821.5, EMA50 at ₹1804.6, EMA100 at ₹1778.2, EMA200 at ₹1749.4. Simple moving averages include SMA5 at ₹1853.7, SMA10 at ₹1829.7, SMA20 at ₹1811.6, SMA30 at ₹1829.5, SMA50 at ₹1797.4, SMA100 at ₹1763.9, SMA150 at ₹1759.1, SMA200 at ₹1731.9.

Support levels for Sun Pharmaceutical are placed at First Support ₹1865.50, Second Support ₹1856.60, Third Support ₹1848.30. Resistance levels are seen at First Resistance ₹1882.70, Second Resistance ₹1891.00, Third Resistance ₹1899.90. Sun Pharmaceutical Industries Ltd. shareholding pattern shows promoter holding at 54.48%, FII holding at 15.94%, DII holding at 0%, public holding at 8.48%.

Sun Pharmaceutical Fundamentals

Market Cap
Market Leader
4,46,948.10 Cr.
PE Ratio (TTM)
Above industry Median
38.90
Dividend Yield
Above industry Median
0.90
Net Profit TTM
5.0% incr over last year
11,479.42
Net Profit Growth
5.0% incr over last year
11,479.42
PEG Ratio
High in industry
7.70
ROE
9% decr over last year
13.73
Operating Revenue TTM
58,462.04
Operating Revenue Growth
11.2% incr over last year
Book Value
Above industry Median
5.30
MFI
MFI Overbought
78.06
RSI
RSI is mid-range
66.93
EPS (TTM)
47.80
Debt to Equity
0.05
Face Value
1
Operating Profit Margin Qtr.
29.34
Operating Profit Qtr.
3,954.20
Net Profit Qtr.
2,714.03
Operating Revenue Qtr.
14,611.79
PB Ratio
5.30

Sun Pharmaceutical Financials

*All values are in Rs. Cr
Loading chart...
Indicator
Mar 2026
Dec 2025
Sep 2025
Jun 2025
Mar 2025
Total Revenue4,923.885,687.774,548.115,601.967,185.74
Operating Expense3,594.913,929.173,364.523,710.814,196.28
Operating Profit1,328.971,758.601,183.591,891.152,989.46
Depreciation325.97338.53336.30299.03291.96
Interest216.92244.17248.33223.29217.42
Tax215.02482.06107.53431.35611.62
Net Profit608.70705.44564.22753.532,000.46

SUNPHARMA Stock Recommendation by HDFC

View Call ↗

Research Type

Equity , Long Term

Buy Range

1,706 - ₹0

Target Price

2,000

Stop Loss

-

Target Date

23 Aug 26

Potential Returns

17.23 %

View Call ↗

Sun Pharmaceutical Technicals

Sun Pharmaceutical Industries Ltd. EMA & SMA

1862.30

-12.10 (-0.65%)

Bullish Moving Average

16

Bearish Moving Average

0

Day EMA5 ₹1855.5
Day EMA10 ₹1838.5
Day EMA12 ₹1834.6
Day EMA20 ₹1826
Day EMA26 ₹1821.5
Day EMA50 ₹1804.6
Day EMA100 ₹1778.2
Day EMA200 ₹1749.4

Sun Pharmaceutical Support and Resistance

Resistance

First Resistance₹1882.70
Second Resistance₹1891.00
Third Resistance₹1899.90

Support

First Support₹1865.50
Second Support₹1856.60
Third Support₹1848.30

Technical Indicators

Day RSI66.93
Day MFI78.06
Day ADX17.39
Day Commodity Channel Index166.70
William-20.54
Day MACD13.13
Day MACD Signal Line5.45
Day ATR30.50
Day ROC1257.36
Day ROC211.84

Sun Pharmaceutical Shareholding Pattern

Held ByDec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Promoter54.554.554.554.554.554.5
FII181817.316.616.115.9
DII18.618.619.520.220.921.1
Public8.98.98.58.78.68.5

Sun Pharmaceutical Delivery And Volume

PeriodCombined Delivery VolumeNSE+BSE Traded Volume AvgDaily Avg Delivery Volume %
Day10.08 L14.38 L70.10%
Week14.64 L22.47 L65.15%
1 Month18.25 L27.49 L66.39%
6 Month21.54 L33.6 L64.09%

Sun Pharmaceutical SWOT Analysis

Strengths14
Weakness11
Opportunity9
Threats1

Benjamin Graham Value Screen

Turnaround Potential (DVM)

Strong Momentum: Price above short, medium and long term moving averages

Stocks with Consistent Share Price Growth (subscription)

Annual Profit Growth higher than Sector Profit Growth

High Momentum Scores (Technical Scores greater than 50)

Relative Outperformance versus Industry over 1 Week

Growth in Quarterly Net Profit with increasing Profit Margin (YoY)

Companies with Low Debt

Annual Net Profits improving for last 2 years

Book Value per share Improving for last 2 years

Near 52 Week High

RSI indicating price strength

Stocks near 52 Week High with Significant Volumes

Sun Pharmaceutical Corporate Action

Ex-Date
Dividend Amount
Dividend Type
Record Date
Instrument Type
07 Jul, 20265FINAL07 Jul, 2026Equity Share
05 Feb, 202611INTERIM05 Feb, 2026Equity Share
07 Jul, 20255.5FINAL07 Jul, 2025Equity Share
06 Feb, 202510.5INTERIM06 Feb, 2025Equity Share
12 Jul, 20245FINAL12 Jul, 2024Equity Share
09 Feb, 20248.5INTERIM09 Feb, 2024Equity Share
28 Jul, 20234FINAL28 Jul, 2023Equity Share
08 Feb, 20237.5INTERIM08 Feb, 2023Equity Share
19 Aug, 20223FINAL22 Aug, 2022Equity Share
09 Feb, 20227INTERIM10 Feb, 2022Equity Share

Sun Pharmaceutical Stock Comparison

Financials
Price (₹)₹1,410.90₹761.40₹1,218.10₹1,880₹2,461₹167.45
% Change1.34%-1.00%1.09%2.17%-0.89%-2.89%
Revenue TTM (₹ Cr)₹1,753.96₹2,124.33₹2,192.49₹9,203.54₹14,277.64₹8,869.07
Net Profit TTM (₹ Cr)₹246.74₹591.79₹348.91₹924.36₹1,912.93₹-325.93
PE TTM95.0072.5074.3038.6053.20-68.50
1 Year Return192.0833.6363.5239.386.71-16.14
ROCE24.3227.5618.3825.6514.322.29

FAQ's on SUNPHARMA

Desktop BannerMobile Banner
Invest Anytime, Anywhere
Play StoreApp Store
Open Free Demat Account Online

By signing up I certify terms, conditions & privacy policy